The FDA has approved Hemangeol (propranolol hydrochloride), from Pierre Fabre, as treatment for �proliferating infantile Haemangioma requiring systemic therapy�. Hemangeol...
Pierre Fabre Dermatologie Laboratories have, on 6 May 2014, obtained European Commission authorization to market Hemangiol (propranolol), the first and...